Related Experiment Videos
Neuroleptic malignant syndrome: a case for electroconvulsive therapy
C C Harland1, M M O'Leary, R Winters
1Department of Medicine, Dudley Road Hospital, Birmingham, UK.
Postgraduate Medical Journal
|January 1, 1990
Summary
Electroconvulsive therapy effectively treated a prolonged case of neuroleptic malignant syndrome (NMS). This review covers NMS and its treatment options.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Neuroleptic malignant syndrome (NMS) is a rare but life-threatening condition.
- It is characterized by hyperthermia, muscle rigidity, autonomic instability, and altered mental status.
- NMS is typically associated with the use of antipsychotic medications.
Observation:
- A patient presented with a prolonged and refractory NMS.
- Conventional treatments for NMS were ineffective in this case.
- Electroconvulsive therapy (ECT) was considered as a last resort.
Findings:
- The patient's NMS resolved successfully following a course of electroconvulsive therapy.
- ECT appears to be a viable and effective treatment option for refractory NMS.
- This case highlights the potential utility of ECT in managing severe NMS.
Implications:
- ECT may offer a valuable therapeutic alternative for patients with severe or treatment-resistant NMS.
- Further research is warranted to elucidate the mechanisms underlying ECT's efficacy in NMS.
- Clinicians should consider ECT in the management of refractory NMS cases.